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Abstract: Pterostilbene, a polyphenolic compound present in grapes and other fruits, has been demonstrated to
inhibit growth and induce apoptosis and autophagy in some cancer cell types. We found that pterostilbene at the
IC90 concentration of 44 µM inhibited proliferation and induced apoptosis in MOLT4 human leukemia cells.
Treatment with pterostilbene resulted in a transient accumulation of cells in the G0/G1-cell cycle phase followed
by the S-phase arrest. Pterostilbene-induced apoptotic death of MOLT4 cells was mediated by caspase-3 activa-
tion and was accompanied by the disruption of mitochondrial membrane potential, phosphatidylserine external-
isation and internucleosomal DNA fragmentation. Our results suggest that pterostilbene could serve as a poten-
tial additional chemotherapeutic agent for the treatment of leukemia. (Folia Histochemica et Cytobiologica 2012,
Vol. 50, No. 4, 574–580)
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Introduction
Pterostilbene (trans-3,5-dimethoxy-4’-hydroxystil-
bene, Figure 1A) is a natural phytoalexin found in
grapes and other fruits [1, 2]. It has been shown to
have antifungal, antioxidant, anti-inflammatory and
anti-diabetic properties [3–5]. Pterostilbene is a dim-
ethylated structural analogue (Figure 1A) of resver-
atrol (trans-3,4’,5-trihydroxystilbene), an extensively
studied constituent of wine. Despite the anti-cancer
activity shown in experimental studies, the potential
clinical application of resveratrol is limited due to its
poor bioavailability [6]. However, pterostilbene has
greater bioavailability than resveratrol [6], and the
results of many studies suggest that it may be a prom-
ising chemotherapeutic agent. Pterostilbene has been
found to exert antiproliferative and proapoptotic ef-
fects in various cancer types, such as lung, gastric and
prostate cancer as well as in melanoma, hepatoma and
leukemic cell lines [7–12]. However, the mechanisms
of pterostilbene activity in cancer cell lines have not
been fully elucidated. Interstingly pterostilbene has
been found to induce both apoptosis and autophagy in
bladder [13] and breast cancer cells [14]. Pterostilbene
inhibited 12-O-tetradecanoylphorbol 13-acetate (TPA)-
induced invasion, migration and metastasis of human
hepatoma HepG2 cells by the down-regulation of met-
alloproteinase-9 (MMP-9) gene expression [11]. More-
over, pterostilbene suppressed heregulin-b-mediated
cell invasion, motility and cell transformation of MCF-7
human breast carcinoma cells by decreasing the MMP-9
activity [15]. It has been found that dietary administra-
tion of pterostilbene effectively reduced azoxymethane-
-induced formation of colonic aberrant crypt foci, pre-
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neoplastic lesions and adenomas in mice [16]. More-
over, pterostilbene exerted chemopreventive effects in
urethane-induced murine lung tumours [17] and in-
hibited 7,12-dimethylbenz[a]anthracene (DMBA)/
/TPA-induced skin tumour formation [18].
The effective action of a potential chemotherapeu-
tic agent should result in the maximal elimination of
cancer cells. However, in most studies of pterostilbene
activity, the IC90 concentration classically used in toxi-
cological studies has not been determined. Therefore,
the aims of our investigation were: (i) to find the con-
centration of pterostilbene required to inhibit growth
of MOLT4 human leukemia cells by 90% (IC90), and
(ii) establish mechanisms of cell death induced by
pterostilbene at the IC90 concentration.
Material and methods
Chemicals. Pterostilbene was purchased from Sigma-Ald-
rich (USA). Pterostilbene stock solutions (200 mM) were
prepared in dimethyl sulphoxide (DMSO, Sigma-Aldrich).
Neutral red and RNase A were obtained from Sigma-Ald-
rich (USA). Propidium iodide (PI) and H2DCFDA (2’,7’-
-dichlorodihydrofluorescein diacetate) were purchased from
Molecular Probes (USA). JC-1 (5,5’,6,6’-tetrachloro-
1,1,3,3’-tetraethylbenzimidazolylcarbocyanine iodide) was
purchased from Calbiochem (USA).
Cell culture. The MOLT4 cell line (human lymphoblastic
leukemia cell line) was kindly provided by Dr. E. Augustin
(Department of Pharmaceutical Technology and Biochem-
istry, Gdansk University of Technology, Poland). MOLT4
cells were maintained at 37°C in a humidified atmosphere
containing 5% CO2, in RPMI 1640 medium (Sigma-Aldrich,
USA) supplemented with 10% heat-inactivated fetal bovine
serum (Sigma-Aldrich, USA) and antibiotics (100 IU/mL
penicillin and 100 µg/mL streptomycin (Sigma-Aldrich,
USA).
Cytotoxicity assay. The cytotoxic effect of pterostilbene
was determined by the neutral red uptake assay which is
based on the ability of viable cells to incorporate the supra-
vital dye neutral red into lysosomes. MOLT4 cells (1.5 × 104/
/mL) were exposed to pterostilbene at concentrations of be-
tween 0 and 100 µM for 48 h (about three population dou-
blings of MOLT4 cells). Control cells were treated with the
solvent (DMSO) alone. In all experiments, the DMSO con-
centration was never higher than 0.1% (v/v) and did not
affect cell growth. After 48 h of treatment, cells were cen-
trifuged, and washed twice with pre-warmed PBS (Phos-
phate-Buffered Saline, Sigma-Aldrich, USA). Supernatants
were removed, cells were suspended in neutral red solution
(final concentration: 33 µg/mL) and then incubated for 2.5 h
at 37°C. Next, cells were washed twice with pre-warmed PBS,
supernatants were removed and acetic acid/ethanol solu-
tion (1% acetic acid in 50% ethanol, v/v) was added to each
sample. The absorbance was measured at l = 540 nm using
a microplate reader (Jupiter; ASYS Hitech GmbH, Aus-
tria). The number of viable cells was expressed as the per-
centage of control. The concentration of pterostilbene re-
quired to inhibit cell growth by 90% (IC90) was calculated.
Cell cycle analysis. After treatment, cells were collected,
washed with cold PBS, and fixed in ice-cold 70% ethanol
overnight at –20°C. Thereafter, cells were washed in ice-cold
PBS, suspended in staining solution (50 µg/mL propidium
iodide, PI, and 25 µg/mL DNase-free RNase A in PBS) and
incubated for 30 min in the dark at 37°C. Samples were anal-
ysed by flow cytometry (Becton Dickinson FACScan, USA).
Annexin V-FITC/PI assay. Phosphatidylserine external-
isation was determined using an Annexin V-FITC Apopto-
sis Detection Kit (BD Pharmingen, USA) according to the
manufacturer’s protocol. After treatment, cells were washed
with PBS and stained with PI and FITC-conjugated Annex-
in V. Samples were analysed by flow cytometry.
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Figure 1. Chemical structure of pterostilbene (panel A).
Effect of pterostilbene on viability of MOLT4 cells (panel B).
MOLT4 cells were incubated for 48 h with increasing
concentrations of pterostilbene and their viability was
assessed by the neutral red uptake assay. Data is presented
as means ± SD of three independent experiments
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DNA fragmentation analysis. DNA fragmentation was
examined as described previously [19]. DNA fragments were
fractionated by electrophoresis on 1.8% agarose gels, stained
with ethidium bromide, and photographed using Gel Doc
2000 (Bio-Rad, Italy).
Caspase-3 activity assay. Caspase-3 activity was mea-
sured using a FITC-conjugated Monoclonal Active Caspase-
3 Antibody Apoptosis Kit I (BD Pharmingen, USA) accord-
ing to the manufacturer’s protocol. After treatment, cells
were stained with FITC-conjugated anti-active caspase-3
antibody. Samples were analysed by flow cytometry.
Measurement of mitochondrial membrane potential.
Analysis of mitochondrial membrane potential was per-
formed using the JC-1 dye as described previously [19]. Sam-
ples were analysed by flow cytometry.
Detection of reactive oxygen species. The intracellular
production of reactive oxygen species (ROS) was analysed
by flow cytometry. Cells were exposed to pterostilbene or
DMSO (control). 30 min before the end of incubation,
H2DCFDA was added at a final concentration of 10 µM.
Cells were then washed, suspended in cold PBS, and analy-
sed for DCF fluorescence by flow cytometry.
Statistical analysis. Statistical analysis was performed
using Statistica 9 software (Statsoft, Poland). Data is ex-
pressed as means ± SD. Statistical differences were evalu-
ated using the Mann-Whitney U test. Differences were con-
sidered significant at p < 0.05.
Results
Effect of pterostilbene on cell viability and cell cycle
The treatment of MOLT4 cells with pterostilbene for
48 h resulted in a dramatic decrease in cell viability
as assessed by neutral red uptake assay (Figure 1B).
The estimated pterostilbene concentration required
to inhibit growth of MOLT4 cells by 90% (IC90) was
44 µM.
The cell cycle analysis revealed that after 6 h of in-
cubation of MOLT4 cells with pterostilbene at the IC90
concentration, there was a statistically significant
increase in the number of cells in the G0/G1 phase
(Table 1, Figure 2). However, this effect was transient.
After 24 h of incubation with the compound, there was
a significant accumulation of cells in the S-phase, which
was accompanied by a corresponding decrease in the
number of cells in G0/G1 and G2/M fractions (Table 1).
Treatment of cells with 44 µM pterostilbene for 48 h
led to a significant increase of the population of cells
in the sub-G1 fraction (Table 1, Figure 2).
Pterostilbene-induced apoptosis of MOLT4 cells
Phosphatidylserine externalisation, indicative of the
loss of plasma membrane asymmetry, is considered
to be a hallmark of apoptosis. Treatment of MOLT4
cells with 44 µM pterostilbene resulted in a time-de-
pendent statistically significant increase in the num-
ber of early apoptotic and late apoptotic/necrotic cells
(Figures 3A, B). After 12 h of pterostilbene treatment,
Annexin-V+/PI- cells (early apoptotic) and Annexin-
V+/PI+ cells (late apoptotic/necrotic) constituted
about 5% and 9% of the total measured cell popula-
tion, respectively. After 24 h of incubation with pteros-
tilbene, the fractions of Annexin-V+/PI- and Annex-
in-V+/PI+ cells were 16% and 14%, respectively. The
number of early apoptotic and late apoptotic/necrot-
ic cells further increased after 48 h of pterostilbene
treatment: early apoptotic cells constituted about
20%, whereas late apoptotic/necrotic made up 22%
of the total measured cell population (Figures 3A, B).
Since internucleosomal DNA fragmentation is
a typical marker of the late phase of apoptosis, we
examined the effect of pterostilbene on DNA degra-
dation in MOLT4 cells. As shown in Figure 3C, after
12 h and 24 h of treatment with 44 µM pterostilbene,
Table 1. Cell cycle distribution of pterostilbene-treated MOLT4 cells
Time of treatment (h) Cell cycle distribution (% of total cell population)
Sub-G1 ± SD G0/G1 ± SD S ± SD G2/M ± SD
Control 0.5 ± 0.1 37.6 ± 1.2 40.3 ± 0.8 22.1 ± 1.0
6 h 1.2 ± 1.0 47.4 ± 5.6* 31.3 ± 3.4 13.8 ± 0.2
12 h 1.5 ± 1.0 44.4 ± 1.8 41.8 ± 1.4 12.9 ± 0.5
24 h 10.5 ± 5.5 37.2 ± 0.5 44.7 ± 5.2* 7.7 ± 0.8
48 h 29.4 ± 2.2* 23.7 ± 5.9 26.6 ± 1.5 21.0 ± 2.5
Data is presented as means ± SD of three independent experiments; *Statistically significant difference vs. respective fraction in control cells,
p < 0.05
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Figure 2. Cell cycle analysis. MOLT4 cells were treated with 44 µM pterostilbene for 6, 12, 24, and 48 h; control —
untreated cells (flow cytometry analysis, PI staining). Data is representative of three independent experiments which gave
similar results
only slight changes were observed compared to con-
trol, i.e. untreated, cells. An apoptotic ladder-like
pattern was clearly visible only after 48 h of incuba-
tion with the compound.
The activity of caspase-3 is required for the execu-
tive phase of apoptosis. As shown in Figure 3D, 44 µM
pterostilbene led to a statistically significant increase
in the percentage of cells with active caspase-3. After
48 h of treatment, caspase-3 activation was detected
in 32% of the total measured cell population.
Mitochondria play an important role in the intrin-
sic apoptotic pathway. The decrease/loss of mitochon-
drial membrane potential related to mitochondrial
dysfunction is considered to be an apoptotic event.
Therefore, we examined the effect of pterostilbene
on changes of mitochondrial membrane potential in
MOLT4 cells. Results, shown in Figure 3D, demon-
strate that 44 µM pterostilbene induced statistically
significant changes of the mitochondrial membrane
potential. After 48 h of incubation with the compound,
about 20% of cells showed reduced mitochondrial
potential.
Effect of pterostilbene on intracellular
ROS production
To elucidate whether pterostilbene-induced death of
MOLT4 cells is accompanied by oxidative stress, we
examined the effect of this polyphenolic compound
on intracellular ROS (reactive oxygen species) pro-
duction. As shown in Figure 4, compared to untreat-
ed control cells, 4 h and 6 h of treatment with 44 µM
pterostilbene did not change the formation of ROS
in MOLT4 cells. DCF fluorescence, representing the
overall intracellular ROS production, was not altered
in pterostilbene-treated cells compared to control
cells.
Discussion
Recently, many in vitro and in vivo studies have indi-
cated that pterostilbene may be a promising chemo-
therapeutic agent [7–18]. In the present study, we have
presented novel observations that pterostilbene,
a natural resveratrol analogue, induced cell cycle ar-
rest and apoptosis in MOLT4 human leukemia cells.
Our results revealed that treatment of MOLT4
cells for 6 h with pterostilbene at a biologically signi-
ficant IC90 concentration resulted in a transient accu-
mulation of cells in the G0/G1 phase, followed by
S-phase cell cycle arrest after prolonged incubation
with the compound. Pterostilbene-induced G0/G1 cell
cycle arrest has also been observed in AGS human
gastric cancer cells [8] as well as in LNCaP human
androgen-responsive prostate cancer cells [9]. Pteros-
tilbene has been found to cause S-phase cell cycle
arrest in MCF-7 human breast cancer cells [20] and
in HL60 human leukemia cells [12].
Apoptosis is a genetically programmed cell death
that plays a crucial role in both the development and
maintenance of tissue homeostasis. Chemical com-
pounds that affect apoptotic pathways and eliminate
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cancer cells are considered to be promising antican-
cer drugs. In pterostilbene-treated MOLT4 cells, sev-
eral markers of apoptosis were detected. Pterostil-
bene induced time-dependent changes in phosphati-
dylserine externalisation which belongs to early apo-
ptotic events. Similar results have been shown in
pterostilbene-treated K562 human leukemia cells [12].
Additionally, the induction of apoptotic cell death in
MOLT4 cells treated by pterostilbene at the IC90 con-
centration was confirmed by the detection of inter-
Figure 3. Detection of apoptosis in pterostilbene-treated MOLT4 cells. (A) Time-course changes of phosphatidylserine
externalisation induced by pterostilbene in MOLT4 cells (flow cytometry analysis, Annexin V-FITC/PI staining). MOLT4
cells were incubated with 44 µM pterostilbene for 0-48 h. Data is representative of three independent experiments. The
bottom right quadrant of each dot plot represents Annexin V positive/PI negative cells (Annexin V+/PI-) corresponding to
early apoptotic cells, whereas the upper right quadrant represents Annexin V positive/PI positive (Annexin V+/PI+) cells
corresponding to late apoptotic/necrotic cells. (B) Percentage of apoptotic cells (exhibiting phosphatidylserine externalisa-
tion) induced by pterostilbene (flow cytometry analysis, Annexin V-FITC/PI staining). MOLT4 cells were incubated with
44 µM pterostilbene for 0-48 h. Data is presented as means ± SD of three independent experiments.
* statistically significant difference compared to the respective data of control (untreated cells), p < 0.05. (C) DNA
fragmentation induced by pterostilbene. MOLT4 cells were incubated with 44 µM pterostilbene for 0-48 h. M, 100-10,000
bp DNA marker; lane 1, control (untreated cells); lanes 2-4, 12, 24, and 48 h of pterostilbene treatment, respectively.
DNA degradation was analysed by agarose gel electrophoresis. Data is representative of three independent experiments.
(D) Effect of pterostilbene on caspase-3 activation and changes of mitochondrial membrane potential. MOLT4 cells were
treated with 44 µM pterostilbene for 48 h. Caspase-3 activation was determined by flow cytometry after staining with anti-
active caspase-3 antibody. Changes in mitochondrial membrane potential were analysed by flow cytometry after JC-1
staining. Data is presented as means ± SD of three independent experiments. * statistically significant difference compa-
red to the respective data of control (untreated) cells, p < 0.05
nucleosomal DNA fragmentation. These findings
were supported by the results of the cell cycle analy-
sis, since the proportion of cells in the sub-G1 frac-
tion, indicative of apoptotic DNA cleavage, increased
significantly after 48 h of pterostilbene treatment.
Pterostilbene-induced apoptotic DNA fragmentation
has also been detected in MCF-7 and MDA-MB-231
human breast cancer cells [20], NCI-H460 and SK-
MES-1 human lung cancer cells [7] as well as in AGS
human gastric cancer cells [8].
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Similarly to our observations, caspase-3 dependent
apoptosis has been found in other pterostilbene-treat-
ed cancer cell lines such as SK-MEL-2 and MeWo
human melanoma cells [10], NCI-H460 and SK-MES-1
human lung cancer cells [7] as well as AGS human
gastric cancer cells [8]. The finding in the present study
of the disruption of mitochondrial membrane poten-
tial by pterostilbene at the IC90 concentration was in-
dicative of the intrinsic apoptotic pathway activation
in MOLT4 cells. Mitochondrial depolarisation was
also detected in pterostilbene-treated MCF-7 and
MDA-MB-231 human breast cancer cells [20].
Despite exhibiting antioxidant properties [4],
pterostilbene has been shown to induce oxidative
stress by increasing superoxide anion levels in MCF-
7 and MDA-MB-231 breast cancer cell lines [20]. Our
results suggest that changes of ROS levels in pteros-
tilbene-treated cancer cells may depend on the type
of tested cells, since we did not observe oxidative stress
in MOLT4 cells.
In conclusion, we demonstrated that pterostilbene
at the IC90 concentration was able to inhibit prolifer-
ation and induce apoptosis of MOLT4 human lym-
phoblastic leukemia cells. The results of this study
suggest that this polyphenolic compound could serve
as a potential additional chemotherapeutic agent for
the treatment of leukemia.
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